Viewing Study NCT06938906


Ignite Creation Date: 2025-12-26 @ 5:20 PM
Ignite Modification Date: 2025-12-31 @ 3:22 PM
Study NCT ID: NCT06938906
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-24
First Post: 2025-04-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Multimodal Therapy Impact on Pancreatic Cancer Survival
Sponsor: National Cheng Kung University
Organization:

Study Overview

Official Title: Survival Outcome Analysis on the Strategy Shift Integrating a Multimodal Therapy of Neoadjuvant Chemotherapy and Extended Pancreatectomy in Pancreatic Cancer: A Clinical Study From a Retrospective Cohort in a Single Institute
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2025-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: MMTIPS
Brief Summary: The goal of this retrospective cohort study is to analyze change of treatment strategies affect the survival outcomes in patients of pancreatic cancer who received curative-intent treatment. The main question it aims to answer is:

Hypothesis: Change of treatment strategies involving increased utility of neoadjuvant chemotherapy and aggressive surgical approaches of extended pancreatectomy improved the overall and progression free survival in the patients with pancreatic cancer.

Participants received curative treatment for pancreatic cancer.
Detailed Description: This study is to analyze the change of treatment strategies and shift of the paradigm over time in a single center. Researchers plan to see the impact of the evolvement to the survival outcomes in pancreatic cancer.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: